Evidence map›Paper›PMID 27303435›Full record

ReviewFrontiers in genetics2016

Melanocortin 1 Receptor: Structure, Function, and Regulation.

Erin M Wolf Horrell, Mary C Boulanger, John A D'Orazio

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 267 citations in OpenAlex.

  1. Trial
  2. Article
  3. Features of Skin of Color.Deutsches Arzteblatt international · 2026
    Review
  4. Article
  5. Article
  6. Ultrarapid MC1R protein and associated plumage color evolution in the domestic chicken.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Regenerative biomaterials · 2026
    Review
  13. Review
  14. medRxiv : the preprint server for health sciences · 2025
    Article
  15. Novel mutation sites in theJournal of advanced veterinary and animal research · 2025
    Article
  16. Loss-of-function mutations inBiology letters · 2025
    Article
  17. Review
  18. Review
  19. Article
  20. Detection ofAnimals : an open access journal from MDPI · 2025
    Article

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Erin M Wolf HorrellDepartment of Physiology, University of Kentucky College of Medicine Lexington, KY, USA.
Mary C BoulangerMarkey Cancer Center, University of Kentucky College of Medicine Lexington, KY, USA.
John A D'OrazioDepartment of Physiology, University of Kentucky College of MedicineLexington, KY, USA; Markey Cancer Center, University of Kentucky College of MedicineLexington, KY, USA; Departments of Pediatrics, Toxicology and Cancer Biology, Physiology, and Pharmacology and Nutritional Sciences, University of Kentucky College of MedicineLexington, KY, USA.
Markey Cancer Center · USUniversity of Kentucky · US

Funding

The role of Mc1r in melanocytic UV-induced DNA damage and repair responsesR01CA131075 · NCI · UNIVERSITY OF KENTUCKY · PI D'ORAZIO, JOHN A · 2010 to 2020
$3.3M
Interdisciplinary Research Training in Cancer BiologyT32CA165990 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers, KATHLEEN L. O'CONNOR · 2013 to 2026
$3.2M
NCI NIH HHS R01 CA131075NCI NIH HHS T32 CA165990
6 · The paper itself

Abstract

The melanocortin 1 receptor (MC1R) is a melanocytic Gs protein coupled receptor that regulates skin pigmentation, UV responses, and melanoma risk. It is a highly polymorphic gene, and loss of function correlates with a fair, UV-sensitive, and melanoma-prone phenotype due to defective epidermal melanization and sub-optimal DNA repair. MC1R signaling, achieved through adenylyl cyclase activation and generation of the second messenger cAMP, is hormonally controlled by the positive agonist melanocortin, the negative agonist agouti signaling protein, and the neutral antagonist β-defensin 3. Activation of cAMP signaling up-regulates melanin production and deposition in the epidermis which functions to limit UV penetration into the skin and enhances nucleotide excision repair (NER), the genomic stability pathway responsible for clearing UV photolesions from DNA to avoid mutagenesis. Herein we review MC1R structure and function and summarize our laboratory's findings on the molecular mechanisms by which MC1R signaling impacts NER.

Indexed as

ASIPATRDNA repairMC1RmelanocortinmelanocytemelanomaβD3

Identifiers

PMID27303435
PMCPMC4885833
OpenAlexW2435708719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.